These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15506049

  • 1. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B, Földy D, Hefter H, Auff E, Schnider P.
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W.
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Botulinum toxin: a new dimension for spasticity].
    Reichel G.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():65-9. PubMed ID: 17724971
    [Abstract] [Full Text] [Related]

  • 10. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC, Bowen B, Liu J, Brin MF.
    Arch Phys Med Rehabil; 2006 Jun 21; 87(6):786-92. PubMed ID: 16731213
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin A in the treatment of hemiplegic spastic foot drop--clinical and functional outcomes.
    Chua KS, Kong KH, Lui YC.
    Singapore Med J; 2000 May 21; 41(5):209-13. PubMed ID: 11063169
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 May 21; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot.
    Baricich A, Carda S, Bertoni M, Maderna L, Cisari C.
    J Rehabil Med; 2008 Nov 21; 40(10):870-2. PubMed ID: 19242626
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M, O'Flaherty SJ, Waugh MC.
    Arch Phys Med Rehabil; 2007 Jan 21; 88(1):1-10. PubMed ID: 17207668
    [Abstract] [Full Text] [Related]

  • 19. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L, Ashford S.
    Disabil Rehabil; 2007 Dec 15; 29(23):1806-12. PubMed ID: 18033605
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.